Search clinical trials for: MAZE III
Total 0 results
Nothing found
Sponsors and Collaborators
- DnaNudge Ltd
- National Cancer Institute Center to Reduce Cancer Health Disparities
- Centre Hospitalier de Saint-Lô
- AIRWEAVE PTE. LTD.
- Osaka University Japan
- Samu of Necker, Paris, France
- Gamze Durmazoğlu
- Occupational and Environmental Medicine, Sahlgrenska UH, Gothenburg
- Song Zhao
- Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company
- Robin Vanderpool
- Roncarolo, Maria Grazia, MD
- Imbrium Therapeutics
- Steno Diabetes Center Sjaelland
- Centre de néphrologie Polyclinique Médipôle Saint-Roch, Rue Ambroise Croizat
- Xinjiang Tumor Hospital
- Joel Town
- Nanfang Hospital of Southern Medical University, Guangdong of China
- Lin Medical Center, Haifa
- People's Hospital of Baise
- View Full List
Medical Conditions
- Periodontology
- Nutritional Edema
- Low Birthweight, Extremely (999 Grams or Less)
- Fecal Elastase-1 Test
- Pediatric Anaplastic Large Cell Lymphoma
- Moderate to Severe Functional Impairments
- Myeloproliferative Disease
- Idiopathic Gastric Stasis
- Suspected Neonatal Encephalopathy
- Heart Defect, Congenital
- Radial Artery Catheterization
- Canthal Lines
- Postmenopausal Diabetes
- Acute Necrotizing Encephalopathy
- Pertussis Immunisation
- Ketamine Treatment
- Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
- Improved Vocal Fold Status
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Influenza and Other Novel Respiratory Viruses
- View Full List
Drug Interventions
- Rifaximin
- Pentostatin
- Postoperative analgesia management
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Hydroxychloroquine
- Levobupivacaine, clonidine
- Fludarabine
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Nimotuzumab
- Levcromakalim
- CKD-519
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- 200 µg doxorubicin-containing MNA
- Ombrabulin (AVE8062)
- Toripalimab plus Anlotinib
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- AZD7798
- ESK981
- Bendamustine
- 5-Fluoro-3-Pyridinecarboxylic Acid
- View Full List
CROs by country
- Contract Research Organizations in Angola
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Dominican Republic
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Finland
- Contract Research Organizations in Gambia
- Contract Research Organizations in Malawi
- Contract Research Organizations in Oman
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Spain
- Contract Research Organizations in Switzerland
- Contract Research Organizations in Taiwan
- Contract Research Organizations in Türkiye
- CRO list by country